A Neurosurgeon's Perspective on the Early Clinical Experience With GammaTile Therapy at an NCI-Designated Cancer Center

A Neurosurgeon’s Perspective on the Early Clinical Experience With GammaTile Therapy at an NCI-Designated Cancer Center

Dr. Kimberly Bojanowski Hoang of Emory University describes their experience with GammaTile Therapy, including a product overview, patient selection criteria, procedural workflow, and early clinical outcomes.

Blog

A Neurosurgeon’s Perspective on the Early Clinical Experience With GammaTile Therapy at an NCI-Designated Cancer Center

You may also like:

What’s Happening in Health: Liz Bonis is Joined by a Team to Talk About Brain Tumor Surgery

Westchester Medical Center First in Region to Offer Brain Tumor Therapy That Can Slow Tumor Progression

Vidant, ECU Brody School of Medicine Successfully Perform First-in-State GammaTile Procedure